Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Lyra Therapeutics
AddedFeb 19, 2024
UpdatedJun 18, 2026
Lyra Therapeutics

Lyra Therapeutics

Public

Lyra Therapeutics, Inc.: A clinical-stage biotech firm innovating localized treatments for chronic rhinosinusitis.

HQ
Watertown, MA, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

Lyra Therapeutics is a clinical-stage biotechnology company focused on developing innovative therapies for the localized treatment of chronic rhinosinusitis (CRS). The company's mission is to provide new solutions for CRS, a debilitating inflammatory disease affecting millions of people worldwide. Lyra's approach aims to deliver treatment directly at the site of impact for CRS patients.

The company's work represents a potential shift in the status quo for CRS treatment. Lyra Therapeutics is dedicated to addressing the long-term symptoms of CRS, including nasal congestion, facial pain and pressure, and nasal discharge, which can persist for months or years. Their innovative approach to localized therapy positions them as a potential leader in advancing CRS treatment options.

Lyra Therapeutics - Similar Companies

Lyndra logo

Lyndra

lyndra.com

Lyric Pharmaceuticals logo

Lyric Pharmaceuticals

Cara Therapeutics logo

Cara Therapeutics

Cyrano Therapeutics logo

Cyrano Therapeutics

Exalys Therapeutics logo

Exalys Therapeutics

Kymera Therapeutics logo

Kymera Therapeutics

kymeratx.com

Lytica Therapeutics logo

Lytica Therapeutics

Synspira logo

Synspira

Luma Therapeutics logo

Luma Therapeutics

Lykos Therapeutics logo

Lykos Therapeutics

lykospbc.com

Logical Therapeutics logo

Logical Therapeutics

Transcera logo

Transcera

Aer Therapeutics logo

Aer Therapeutics

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

Halia Therapeutics logo

Halia Therapeutics

Lyra Therapeutics - Quick Facts

Who are Lyra Therapeutics' competitors?

Companies similar to Lyra Therapeutics include Lyndra, Lyric Pharmaceuticals, Cara Therapeutics and Cyrano Therapeutics.

When was Lyra Therapeutics founded?

Lyra Therapeutics was founded in 2014.

Where is Lyra Therapeutics' headquarters located?

Lyra Therapeutics' headquarters is located in Watertown, MA, US.

When was Lyra Therapeutics' last funding round?

Lyra Therapeutics' most recent funding round was for $50M (USD) in May 2023.

How much has Lyra Therapeutics raised to-date?

As of May 26, 2023, Lyra Therapeutics has raised a total of $264.1M (USD).

How many employees does Lyra Therapeutics have?

Lyra Therapeutics has 66 employees as of Feb 6, 2024.

Lyra Therapeutics - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drugs
  • Therapeutics
Tags
  • Healthtech
Unique IDs
  • ein: 000000000
  • secCik: 0001327273
  • ticker: LYRA
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 3840Surgical, Medical, And Dental Instruments And Supplies
  • 3841Surgical And Medical Instruments And Apparatus
ISIC
  • 2520Manufacture of weapons and ammunition
  • 2815Manufacture of ovens, furnaces and furnace burners
  • 3250Manufacture of medical and dental instruments and supplies
Show 42 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 332000Fabricated Metal Product Manufacturing
  • 332900Other Fabricated Metal Product Manufacturing
  • 332990All Other Fabricated Metal Product Manufacturing
  • 332994Small Arms, Ordnance, and Ordnance Accessories Manufacturing
  • 333200Industrial Machinery Manufacturing
  • 333240Industrial Machinery Manufacturing
  • 333248All Other Industrial Machinery Manufacturing
  • 333400Ventilation, Heating, Air-Conditioning, and Commercial Refrigeration Equipment Manufacturing
  • 333410Ventilation, Heating, Air-Conditioning, and Commercial Refrigeration Equipment Manufacturing
  • 333415Air-Conditioning and Warm Air Heating Equipment and Commercial and Industrial Refrigeration Equipment Manufacturing
  • 333900Other General Purpose Machinery Manufacturing
  • 333990All Other General Purpose Machinery Manufacturing
  • 333994Industrial Process Furnace and Oven Manufacturing
  • 333998All Other Miscellaneous General Purpose Machinery Manufacturing
  • 337000Furniture and Related Product Manufacturing
  • 337100Household and Institutional Furniture and Kitchen Cabinet Manufacturing
  • 337120Household and Institutional Furniture Manufacturing
  • 337127Institutional Furniture Manufacturing
  • 339100Medical Equipment and Supplies Manufacturing
  • 339110Medical Equipment and Supplies Manufacturing
  • 339112Surgical and Medical Instrument Manufacturing
  • 339113Surgical Appliance and Supplies Manufacturing
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 333000Machinery Manufacturing
  • 339000Miscellaneous Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research